StocksTelegraph
S&P 500—NASDAQ—DOW—RUSSELL—
NASDAQ · PBYI·Healthcare

Puma Biotechnology, Inc. Stock Analysis & AI Score

Puma Biotechnology, Inc. (PBYI) has an ST Score of 56.1 (B-), driven by its Profitability (A+) and held back by its Financial Strength (D+). Analysts rate it Buy.

Market Closed
$9.82
Prev Close
—
Market Cap
—
Day Range
—
52W Range
—
P/E
—
EPS (TTM)
—
Volume
—
Avg —
Beta
—
56
ST Score
56.1/100B-

Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.

As of
AI Daily Briefing
Analysis by AI
Price History
—
Technical Indicators
FMP
Earnings Surprises
Analyst Forecast
Revenue Mix

Company Information

Employees—
CEO—
SectorHealthcare
IndustryBiotechnology
IPO Date—
Website—
Country—
ExchangeNASDAQ

SEC Filings

Annual Report (10-K)

Filing DateAcceptedLink
Loading…

Quarterly Report (10-Q)

Filing DateAcceptedLink
Loading…
Analyst Price Target
ESG Score
Latest News

ST Score

PBYI
56.1out of 100
Grade B-

Puma Biotechnology, Inc. (PBYI) has an ST Score of 56.1 (B-), driven by its Profitability (A+) and held back by its Financial Strength (D+). Analysts rate it Buy.

Strongest
ProfitabilityA+
Weakest
Financial StrengthD+
All factor grades
  • ProfitabilityA+
  • MomentumA-
  • GrowthC-
  • ValuationD+
  • Financial StrengthD+
  • Piotroski7/9
Score methodology
Press Releases

Contact

PBYI stock: frequently asked questions

What is PBYI's ST Score?

Puma Biotechnology, Inc. (PBYI) has an ST Score of 56.1 (B-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Is PBYI a buy, hold, or sell?

Analysts rate PBYI a Buy. Our ST Score grades it B- (56.1/100). The ST Score is a data-driven signal, not a recommendation.

What are PBYI's factor grades?

Valuation D+, Profitability A+, Financial Strength D+, Momentum A-, Growth C-.

What is PBYI's valuation grade?

Puma Biotechnology, Inc. (PBYI) earns a valuation grade of D+, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

What is PBYI's growth grade?

Puma Biotechnology, Inc. (PBYI) earns a growth grade of C-, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

What is PBYI's profitability grade?

Puma Biotechnology, Inc. (PBYI) earns a profitability grade of A+, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

What is PBYI's financial strength grade?

Puma Biotechnology, Inc. (PBYI) earns a financial strength grade of D+, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

What is PBYI's Piotroski score?

Puma Biotechnology, Inc. (PBYI) has a Piotroski F-Score of 7 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.